Arkolith/Insider Trading/FRTX/Form 4

McAvoy David R.

Gen Counsel, CCO, & SecretaryFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Oct 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2023Option exercise(M)20K——23K
Oct 2, 2023Tax withholding(F)7K$0.98$7K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2023Option exercise(M)20K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-23-033914) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML